Varex Imaging Corporation
NASDAQ:VREXMedical - Devices
+$0.34 today
- Market cap
- $770.71M
- Beta
- 0.90
- P/E (TTM)
- -5.3
- EPS (TTM)
- -$1.97
Volume 0.73M
Average 0.36M
VREX Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
Varex Imaging CorporationNASDAQ: VREX
Accumulated OCI · Q2 FY2026 · quarter ended Apr 2026
Accumulated OCI remains negative
Q2 FY2026 Accumulated OCI was -$5.6M, compared with -$2.4M a year earlier.
Context
- Accumulated OCI amounted to 0.5% of total assets at the end of Q2 FY2026, up 0.3 pp from a year earlier.
- Accumulated OCI increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether Accumulated OCI keeps falling in the next quarterly balance sheet after a -133.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Accumulated OCI history
USD · from the balance sheet
- Latest · FY2025
- (5.2M) USD
- Year-over-year change
- -79.3%
| Period | Period end | Accumulated OCI | YoY change |
|---|---|---|---|
| FY2025 | 2025-10-03 | (5.2M) | -79.3% |
| FY2024 | 2024-09-27 | (2.9M) | -141.7% |
| FY2023 | 2023-09-29 | (1.2M) | -1300.0% |
| FY2022 | 2022-09-30 | 100K | +175921860444060.0% |
| FY2021 | 2021-10-01 | 0 | — |
Accumulated OCI vs competitors
How VREX compares with its peers on the latest reported figures
- VREX's Apr 2026 Accumulated OCI of -$5.6M is the 2nd highest of the 5 companies compared; the peer median is -$57.99M.
- Its year-over-year change of -133.3% is the lowest of 5, against a peer median of +4.3%.
- Accumulated OCI amounts to 0.5% of total assets for VREX, versus a peer median of 1.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Dec 2025 | $0 | +100.0% | — | 0.0% | |
| Apr 2026 | -$5.6M | -133.3% | — | 0.5% | |
| Jun 2026 | -$19.17M | +8.4% | — | 0.8% | |
| Jun 2026 | -$96.8M | +0.2% | — | 1.6% | |
| Jun 2026 | -$1.48B | -35.8% | — | 4.0% | |
| Peer median (excluding VREX) | -$57.99M | +4.3% | — | 1.2% | |
Competitors are the stored peer set for VREX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Oct 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Oct 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 144.6M | 89.4M | 152.6M | 168.7M | 145M |
| Short-term Investments | 0 | 0 | 41.3M | 31.8M | 10.1M |
| Net Receivables | 155.3M | 173.3M | 164.3M | 157.7M | 157.4M |
| Inventory | 224.8M | 303.2M | 277.5M | 264.8M | 299.4M |
| Other Current Assets | 1.5M | 2.1M | 22.6M | 26.9M | 29.9M |
| Total Current Assets | 554.2M | 609.9M | 658.3M | 649.9M | 641.8M |
| Property, Plant & Equipment (Net) | 164.5M | 164.5M | 172.6M | 181.7M | 187.2M |
| Goodwill | 292.2M | 284.5M | 288.5M | 291M | 198.4M |
| Intangible Assets | 50.7M | 33.6M | 22.4M | 16.1M | 14M |
| Long-term Investments | 49.3M | 46.4M | 30.4M | 26.8M | 26.6M |
| Tax Assets | 4M | 2.3M | 41.3M | 4.7M | 2.9M |
| Other Non-current Assets | 32.6M | 43.2M | 36.1M | 46.8M | 36.5M |
| Total Non-current Assets | 593.3M | 574.5M | 591.3M | 567.1M | 465.6M |
| Total Assets | 1.15B | 1.18B | 1.25B | 1.22B | 1.11B |
| Account Payables | 58.8M | 78.2M | 64.7M | 59.1M | 69.9M |
| Short-term Debt | 2.8M | 2.1M | 5.4M | 46.3M | 6.3M |
| Tax Payables | 8M | 11.3M | 13.3M | 8.1M | 0 |
| Deferred Revenue | 9.1M | 14.2M | 17.4M | 7.9M | 13M |
| Other Current Liabilities | 37.3M | 7.9M | 28.6M | 40.5M | 49.3M |
| Total Current Liabilities | 166.6M | 173.1M | 162.8M | 195.9M | 187.2M |
| Long-term Debt | 431.7M | 412.3M | 441.1M | 397.1M | 366M |
| Deferred Tax Liabilities | 2.2M | 500K | 0 | 1.4M | 5.5M |
| Deferred Revenue (Non-current) | 0 | 21.4M | 21.7M | 0 | 0 |
| Other Non-current Liabilities | 31.8M | 12.3M | 19.7M | 50.4M | 32.5M |
| Total Non-current Liabilities | 484.4M | 464.6M | 505.8M | 471.9M | 433.6M |
| Total Liabilities | 651M | 637.7M | 668.6M | 667.8M | 620.8M |
| Common Stock | 400K | 400K | 400K | 400K | 400K |
| Retained Earnings | 33.5M | 63.8M | 118.1M | 70.4M | (5.9M) |
| Accumulated OCI | 0 | 100K | (1.2M) | (2.9M) | (5.2M) |
| Other Stockholders Equity | (0) | 0 | 0 | 0 | 0 |
| Minority Interest | 13.2M | 13.3M | 13.3M | 14.1M | 14M |
| Total Equity | 496.5M | 546.7M | 581M | 549.2M | 486.6M |
| Total Debt | 459.4M | 436.4M | 469.8M | 470.4M | 401.9M |
| Net Debt | 314.8M | 347M | 317.2M | 301.7M | 256.9M |
Varex Imaging Corporation
NASDAQ:VREX
Intrinsic Alpha fair value
Locked
Current Price
$18.15
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.